5 research outputs found
Genetic Determination of Motor Neuron Disease and Neuropathy
Following the completion of the Human Genome Project, a lot of progress has been made in understanding the genetic
basis of motor neuron diseases (MNDs) and neuropathies. Spinal Muscular Atrophies (SMA) are caused by mutations
in the SMN1 gene localized on Chromosome 5q11. Amyotrophic Lateral Sclerosis (ALS) has been found to have at least
18 different types, many of them associated to different genetic loci (e.g. SOD1, ALS2, SETX, FUS, VAPB, ANG, TARDBP
and others), but many of the forms have still not been associated with a particular gene. Sensomotoric hereditary neuropathies
(Charcot-Marie-Tooth) are a large heterogeneous group of various hereditary neuropathies, which have also
been associated with a wide spectrum of genetic mutations, such as PMP22, LITAF, EGR2, P0 protein, KIF1B, MFN2,
RAB7 and others. It is also apparent that more genes are being implicated, mutations discovered, and phenotypes recognised
and broadened. Therefore, a lot of continuing, additional research effort will be required in the coming years to illuminate
pathogenic mechanisms that underlie motor neuron diseases and neuropathies and that could lead to new and
improved treatments
Progression of Optic Neuritis to Multiple Sclerosis in the County of Split-Dalmatia, Croatia
The aim of this study was to determine the incidence of monosymptomatic optic neuritis (MON) and progression of
MON to multiple sclerosis (MS) from the Mediterranean region of southern Europe in the County of Split-Dalmatia,
Croatia during the 11 years period from 1991 to 2001. This study was made retrospectively on the 87 cases (59 female,
aged 25.9Ā±11.3 and 28 male aged 29.9Ā±9.2) of MON, which were treated at the Department of Ophthalmology and Department
of Neurology, Split, University Hospital, from January 1991 to December 2001. In each case the diagnosis was
confirmed by a chart review and cases were ascribed to the data of admittance at hospital. The annual incidence of MON
was 1.9 per 100,000 (95% CI, 0.4ā3.5). The incidence among males was 1.2 (95% CI, 0ā2.9) cases / 100,000 per year and
2.5 (95% CI, 0.1ā4.9) among females. A significant seasonal variations in the incidence of MON was not found (c
2=6.81,
p=0.08). MS developed in 20 of 87 patients (22.9%) and median time was 25 (SE 8) months, (95% CI, 9ā41) after the
MON onset. After two years 12.6% of patients with MON developed MS, 20.6% after 5 years and 22.9% after 10 years. MS
was slightly but not significantly more frequent in women than in men (c
2 =0.72, p=0.3). In conclusion, the progression
of MON to MS in the County of Split-Dalmatia, Croatia was at a relatively moderate frequency
Genetic Determination of Motor Neuron Disease and Neuropathy
Following the completion of the Human Genome Project, a lot of progress has been made in understanding the genetic
basis of motor neuron diseases (MNDs) and neuropathies. Spinal Muscular Atrophies (SMA) are caused by mutations
in the SMN1 gene localized on Chromosome 5q11. Amyotrophic Lateral Sclerosis (ALS) has been found to have at least
18 different types, many of them associated to different genetic loci (e.g. SOD1, ALS2, SETX, FUS, VAPB, ANG, TARDBP
and others), but many of the forms have still not been associated with a particular gene. Sensomotoric hereditary neuropathies
(Charcot-Marie-Tooth) are a large heterogeneous group of various hereditary neuropathies, which have also
been associated with a wide spectrum of genetic mutations, such as PMP22, LITAF, EGR2, P0 protein, KIF1B, MFN2,
RAB7 and others. It is also apparent that more genes are being implicated, mutations discovered, and phenotypes recognised
and broadened. Therefore, a lot of continuing, additional research effort will be required in the coming years to illuminate
pathogenic mechanisms that underlie motor neuron diseases and neuropathies and that could lead to new and
improved treatments
Elektromiografija vanjskog uretralnog i analnog sfinktera te neurografija n. pudendalisa u topiÄkoj neuroloÅ”koj diferencijalnoj dijagnostici : <disertacija>
Sažetak rada "Elektromiografija vanjskog uretralnog i analnog sfinktera te neurografija n. pudendalisa u topiÄkoj neuroloÅ”koj diferencijalnoj dijagnostici" nije dostupan
Elektromiografija vanjskog uretralnog i analnog sfinktera te neurografija n. pudendalisa u topiÄkoj neuroloÅ”koj diferencijalnoj dijagnostici : <disertacija>
Sažetak rada "Elektromiografija vanjskog uretralnog i analnog sfinktera te neurografija n. pudendalisa u topiÄkoj neuroloÅ”koj diferencijalnoj dijagnostici" nije dostupan